Effect of Raltegravir on Endothelial Function in HIV-Infected Patients.

Trial Profile

Effect of Raltegravir on Endothelial Function in HIV-Infected Patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Jun 2015

At a glance

  • Drugs Raltegravir (Primary) ; Antiretrovirals
  • Indications HIV infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 22 Aug 2012 Results published in the JAIDS.
    • 08 Mar 2012 Results presented at the 19th Conference on Retroviruses and Opportunistic Infections.
    • 12 Jan 2010 Planned end date changed from 1 Dec 2009 to 1 Feb 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top